{"schema_version":"secwatch.filing_event.v1","accession":"0000313143-23-000051","form_type":"8-K/A","ticker":"HAE","cik":"0000313143","company_name":"HAEMONETICS CORP","filed_at":"2023-10-12T23:59:59+00:00","discovered_at":"2026-05-14T18:03:31.614324+00:00","generated_at":"2026-06-10T01:19:19.427995+00:00","sec_items":["9.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Haemonetics to acquire OpSens for $2.90/share cash via arrangement","bullets":["Haemonetics to acquire all outstanding shares of OpSens via plan of arrangement under Quebec Business Corporations Act.","Consideration of $2.90 per share in cash; termination fee of $12.075 million payable by OpSens in certain circumstances.","Support and voting agreements with certain shareholders to vote in favor of the arrangement resolution.","Transaction subject to shareholder approval, Quebec Superior Court order, and regulatory clearances."],"urls":{"canonical":"https://secwatch.observer/filing/0000313143-23-000051","json":"https://secwatch.observer/filing/0000313143-23-000051.json","markdown":"https://secwatch.observer/filing/0000313143-23-000051.md","text":"https://secwatch.observer/filing/0000313143-23-000051.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/313143/000031314323000051/0000313143-23-000051-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/313143/000031314323000051/hae-20231010.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T01:19:19.427995+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}